These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 3137096

  • 1. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase.
    Blumenfeld Z, Nahhas F.
    Fertil Steril; 1988 Sep; 50(3):403-7. PubMed ID: 3137096
    [Abstract] [Full Text] [Related]

  • 2. Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation.
    Blumenfeld Z, Ruach M.
    Fertil Steril; 1992 Jul; 58(1):19-23. PubMed ID: 1624004
    [Abstract] [Full Text] [Related]

  • 3. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S, Kubota T, Aso T.
    Horm Res; 1992 Jul; 37 Suppl 1():59-63. PubMed ID: 1427631
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA, Moghissi KS.
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [Abstract] [Full Text] [Related]

  • 6. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD, Simon JA, Rifka SM, Falk RJ.
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [Abstract] [Full Text] [Related]

  • 7. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
    Messinis IE, Bergh T, Wide L.
    Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
    [Abstract] [Full Text] [Related]

  • 8. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation.
    Agarwal SK, Buyalos RP.
    Hum Reprod; 1995 Feb; 10(2):328-31. PubMed ID: 7769057
    [Abstract] [Full Text] [Related]

  • 9. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C, Kaplan DR, Sarosi P, Essig MN, Licciardi FL, Keltz M, Levitz M.
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [Abstract] [Full Text] [Related]

  • 10. A short course of menotropin after clomiphene failure in infertile women with luteal phase defects.
    Wu CH.
    J Reprod Med; 1989 Oct; 34(10):807-10. PubMed ID: 2507780
    [Abstract] [Full Text] [Related]

  • 11. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL, Rebar RW, Schreiber JR, Vaitukaitis JL.
    Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
    [Abstract] [Full Text] [Related]

  • 12. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J, De Vits A, Joostens M, Van Royen E.
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [Abstract] [Full Text] [Related]

  • 13. Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction.
    Kistner RW.
    Fertil Steril; 1976 Jan; 27(1):72-82. PubMed ID: 1245245
    [Abstract] [Full Text] [Related]

  • 14. Luteal phase support in ovarian induction cycles using human chorionic gonadotropin or oral progestagens.
    Zayed FF, El-Jallad MF, Al-Chalabi HA.
    Saudi Med J; 2003 Jan; 24(1):34-6. PubMed ID: 12590270
    [Abstract] [Full Text] [Related]

  • 15. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N, DeCherney AH, Tarlatzis BC, Zuckerman AL, Polan ML, Dlugi AM, Graebe R, Barnea ER, Naftolin F.
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [Abstract] [Full Text] [Related]

  • 16. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
    Peñarrubia J, Balasch J, Fábregues F, Creus M, Casamitjana R, Ballescá JL, Puerto B, Vanrell JA.
    Hum Reprod; 1998 Dec; 13(12):3315-8. PubMed ID: 9886506
    [Abstract] [Full Text] [Related]

  • 17. Is the corpus luteum normal after ovulation induction?
    Lenz S, Lindenberg S.
    J Clin Ultrasound; 1990 Dec; 18(3):155-9. PubMed ID: 2155933
    [Abstract] [Full Text] [Related]

  • 18. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
    Hara S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
    [Abstract] [Full Text] [Related]

  • 19. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D, Pellicer A, Guanes PP, Remohí J, Simón C.
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [Abstract] [Full Text] [Related]

  • 20. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
    Yilmaz B, Kelekci S, Savan K, Oral H, Mollamahmutoglu L.
    Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.